How to Change Your Mind
Michael Pollan's 2018 book brought psychedelic research to a mainstream audience in a way no previous work had managed. It covers the history of psychedelics from their mid-century clinical use through prohibition and into the current research renaissance, focusing on psilocybin and LSD trials for depression, addiction, and end-of-life anxiety.
Pollan visits the labs at Johns Hopkins (Roland Griffiths), NYU (Stephen Ross), and Imperial College London (Robin Carhart-Harris). He interviews the researchers, therapists, and underground guides who kept psychedelic therapy alive during the prohibition decades. He also undergoes guided sessions himself with psilocybin, LSD, and 5-MeO-DMT, reporting his experiences with journalistic detachment.
The book's cultural impact was significant. It helped shift public perception of psychedelics from counterculture relic to legitimate medical research. Oregon's psilocybin therapy ballot measure and multiple FDA breakthrough therapy designations followed in its wake.
Key takeaways
- –Psilocybin produces measurable, lasting reductions in depression and anxiety in clinical settings, with effects persisting months after a single session.
- –The 'default mode network' hypothesis — that psychedelics work by temporarily disrupting habitual neural patterns — became the dominant explanatory framework.
- –Set and setting are not hippie folklore; they are the primary determinants of outcome in clinical trials.
- –The underground therapy community maintained institutional knowledge for decades after prohibition shut down legal research.
- –Pollan's mainstream credibility helped destigmatize psychedelic research in public discourse.